Five-year treatment-free and overall survival outcomes of active surveillance in 672 patients with localized invisible and visible prostate cancer (PC) on magnetic resonance imaging (MRI), prostate specific antigen (PSA) levels of 20 ng/mL, and Gleason scores of 3 + 3 or 3 + 4,...
The latest data on malignant tumor surveillance, released by the National Cancer Center in 2022, reveals that the proportion of prostate cancer (PCa) among male malignancies has increased from 3.5 to 5.3%, with its incidence consistently ranking sixth among male malignancies [1]. The clinical adoption...
The incidence of female breast cancer has increased by approximately 0.5% annually since the mid-2000s [1]. Currently, breast cancer is the most commonly diagnosed malignant disease among women, accounting for 31% of all newly diagnosed cancers [2]. The status of axillary lymph nodes (ALN) is a critical...
Colorectal cancer ranks among the most common cancers globally, and rectal cancer specifically accounts for a significant portion of disease burden. Rectal cancer is the eighth most frequently diagnosed cancer worldwide and causes approximately 340,000 deaths annually [1]. In non-metastatic cases, curative...